Description
DURATIA 90 MG
Indications
DURATIA 90 MG is primarily indicated for the management of premature ejaculation in adult men. It is designed to enhance the control over ejaculation and improve sexual satisfaction. This medication is particularly beneficial for men who experience ejaculation within one minute of penetration, providing a solution to a condition that can significantly affect quality of life and intimate relationships.
Mechanism of Action
The active ingredient in DURATIA 90 MG is Dapoxetine, which is a selective serotonin reuptake inhibitor (SSRI). Dapoxetine works by increasing the levels of serotonin in the synaptic cleft, which in turn enhances the delay of ejaculation. By modulating serotonin’s effects on the ejaculatory reflex, Dapoxetine effectively prolongs the time to ejaculation, allowing for improved control during sexual activity.
Pharmacological Properties
Dapoxetine is rapidly absorbed following oral administration, with peak plasma concentrations typically reached within 1-2 hours. The drug has a half-life of approximately 1.5 hours, which allows for flexible dosing. Dapoxetine is primarily metabolized in the liver via the cytochrome P450 system, particularly CYP2D6, CYP3A4, and CYP2C19. Due to its pharmacokinetic profile, Dapoxetine is suitable for on-demand use, allowing patients to take the medication shortly before sexual activity.
Contraindications
DURATIA 90 MG should not be used in individuals with a known hypersensitivity to Dapoxetine or any of the excipients in the formulation. It is contraindicated in patients with a history of cardiac conditions such as heart failure, conduction abnormalities, or those who have experienced syncope. Additionally, it should not be administered to individuals taking monoamine oxidase inhibitors (MAOIs) or other SSRIs, as this could lead to serious drug interactions.
Side Effects
Like all medications, DURATIA 90 MG may cause side effects. Commonly reported adverse effects include nausea, headache, dizziness, and diarrhea. These effects are generally mild to moderate in severity and often resolve with continued use. However, more serious side effects, such as fainting, severe allergic reactions, or signs of serotonin syndrome (e.g., agitation, hallucinations, rapid heart rate), require immediate medical attention. Patients are advised to discuss any concerning symptoms with their healthcare provider.
Dosage and Administration
The recommended starting dose of DURATIA 90 MG is one tablet taken 1 to 3 hours before anticipated sexual activity. The maximum recommended dose is one tablet per day. It is important to note that DURATIA is not intended for continuous daily use and should be taken only as needed. Patients should follow their healthcare provider’s instructions regarding dosage adjustments based on individual response and tolerability.
Interactions
DURATIA 90 MG may interact with other medications, potentially altering its effectiveness or increasing the risk of side effects. Co-administration with potent CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) is not recommended, as this may lead to increased plasma concentrations of Dapoxetine. Additionally, the use of Dapoxetine with other serotonergic agents can elevate the risk of serotonin syndrome. Patients should inform their healthcare provider of all medications they are currently taking, including over-the-counter drugs and herbal supplements.
Precautions
Clinical Studies
Conclusion
DURATIA 90 MG represents a valuable option for men struggling with premature ejaculation, offering a targeted approach to enhance sexual performance and satisfaction. Its rapid onset of action and favorable pharmacokinetic properties make it an effective choice for on-demand use. As with any medication, it is essential for patients to consult with their healthcare provider to ensure that DURATIA is appropriate for their individual circumstances and to discuss any potential risks or interactions with other medications.
Important
Responsible use of DURATIA 90 MG is crucial for maximizing its benefits while minimizing potential risks. Patients are encouraged to follow their healthcare provider’s recommendations and report any adverse effects or concerns during treatment.
